NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Taurus Vascular

Taurus Vascular

Private
Houston, TexasHealthcare & Life Scienceshttps://www.taurusvascular.com/

Last Round

Grant

Jun 6, 2024

Total Funding Raised

$30,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Taurus Vascular is a medical device company developing the next generation of solutions for peripheral vascular disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

endoleak treatmentaortocaval shuntendoleaksMedTechEndovascular Aneurysm RepairEVARendovascular devicevascular stentaortic aneurysmcardiovascular devicecatheter-delivered deviceimplantable deviceinterventional cardiologyvascular surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Taurus Vascular Comps

Public and private peers based on sector, stage, and business model.

Taurus Vascular comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Taurus Vascular Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 6, 2024
AcceleratorAug 1, 2022

Key People

Founding team and executive leadership

Matthew Kuhn

Founder & CEO

Founding Team

Gray Ritger

Chief Operating Officer

Executive Team

Taurus Vascular Investors

Notable investors and investment history

Taurus Vascular investors
InvestorRounds
Texas New Venture CompetitionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 12, 2026

    Monthly visitors grew 100% MoM.

Taurus Vascular Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Taurus Vascular Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Taurus Vascular's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas
Employee Range3
Year Founded2018
Last FundingJun 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.